ARTICLE | Clinical News
R343: Development discontinued
September 2, 2013 7:00 AM UTC
Rigel discontinued development of R343 after the double-blind, international Phase II SITAR trial in about 300 patients with mild to moderate allergic asthma showed that twice-daily inhaled R343 misse...